Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01344200RecruitingPhase 2
Celecoxib drug study in children on leukemia treatment
This trial studies how celecoxib moves through a child’s body and how much reaches the fluid around the brain and spinal cord. It’s for children (age 2–12) who are in the maintenance phase of certain blood cancers, to better understand dosing and safety.
Ottawa, OntarioAges 2–12 - NCT03111459Recruiting
Endovascular repair for large thoracoabdominal aortic aneurysms
This trial studies a minimally invasive (endovascular) procedure to repair large or risky aneurysms in the aorta near the chest and abdomen. It may help prevent aneurysm rupture and improve outcomes compared with other possible treatments.
Cincinnati, OhioAges 18 years+ - NCT04653610Recruiting
Study immune signals in untreated HIV using extra samples
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
Ghent, Oost-VlaanderenAges 18–65 - NCT06182657Recruiting
Nasopharyngeal cancer response to induction chemotherapy
This study looks at how well nasopharyngeal cancer (NPC) responds to the first round of chemotherapy before other treatments. It aims to see if the amount of tumor shrinkage can help predict outcomes and guide future care for people with advanced NPC.
Nanchang, JiangxiAges 18 years+ - NCT06247501RecruitingPhase 2
CAR-T therapy for children with B-cell ALL needing transplant
This study tests a new type of immune-cell therapy (called CAR-T cells) for children and young adults with a specific blood cancer (B-cell ALL) who need a stem cell transplant. The treatment uses a patient's own T-cells that are modified to find and kill cancer cells with the CD19 marker.
SeoulAges Up to 25 years - NCT07860008Recruiting
Breathing and step exercises for COPD wellness
This study tests a program combining breathing training with step exercises to see if it improves breathing, exercise ability, and quality of life in people with COPD. You may join if you have COPD and are able to do light exercise and fill out questionnaires.
New Taipei City, New Taipei CityAges 40 years+ - NCT07864883Recruiting
3D modeling from MRI for deep endometriosis
This study uses MRI scans to create 3D models of deep endometriosis to help surgeons plan better. It may lead to improved surgical outcomes for people with this condition.
StrasbourgAges 18 years+ - NCT07855640Recruiting
Immunotherapy plus chemo for advanced stomach cancer with fluid in belly
This trial tests a new combination for advanced stomach cancer that has spread and caused fluid buildup in the belly (malignant ascites). It combines an immunotherapy drug (anti-PD-1) with standard chemotherapy and a targeted chemotherapy given directly into the belly to see if it can shrink the cancer and help you feel better.
Hangzhou, ZhejiangAges 18–75 - NCT07366541Recruiting
Predicting oxygen therapy failure using a monitoring device
This study tests a monitoring device to predict if a patient with low oxygen levels will need a breathing tube within 72 hours. It aims to help doctors decide earlier if a patient needs more intensive support.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07866118Recruiting
Immune recovery treatment for adults with sepsis
This study tests a medicine called thymalfasin, which may help the immune system recover in adults with sepsis (a severe infection that causes organ damage). It aims to see if this treatment can improve immune function and possibly outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07868952Enrolling by invitation
Recovery tracking app for women after gynecologic surgery
This study uses a mobile app to guide recovery after laparoscopic or robotic gynecologic surgery, following an enhanced recovery program. It aims to see if using the app helps improve recovery and quality of life.
Wŏnju, Gangwon-doAges 20–70 - NCT07860047RecruitingPhase 2
Peptide vaccine with antibody therapy for prostate cancer
This trial tests a combination of a personalized peptide vaccine and an antibody therapy for men with prostate cancer that has returned after initial treatment. The goal is to see if this approach can control the cancer without needing stronger hormone therapy.
Heidelberg, Baden-WurttembergAges 18–80 - NCT07874321RecruitingPhase 2
Study of MRG003 for advanced thyroid cancer that has progressed on current therapy
This trial tests an investigational drug called MRG003 added to your current treatment for advanced thyroid cancer that has stopped responding. It may help people with specific types of thyroid cancer and certain tumor markers.
Guangzhou, GuangdongAges 18–80 - NCT07871487Recruiting
Brain protein changes after hip or knee replacement surgery
This study looks at whether having hip or knee replacement surgery with spinal anesthesia affects certain proteins in the brain that are linked to memory and thinking. It compares people having surgery with people who have arthritis but are not having surgery, to help understand if the surgery causes any short-term brain changes.
UppsalaAges 55–75 - NCT06130592Recruiting
Ultrasound muscle imaging in pregnancy
This study tests a new ultrasound technique to look at fetal muscles in pregnant women, which might help detect joint or movement problems early. It aims to see if the technique is feasible and could improve prenatal diagnosis.
La Tronche, IsèreAges 18–55 - NCT07173387RecruitingPhase 2
Radiation plus chemo for locally advanced pancreatic cancer
This trial combines focused radiation with a chemotherapy drug combo to help shrink or control locally advanced pancreatic cancer. If it works, this treatment might make the tumor smaller and improve quality of life.
Jinan, ShandongAges 18–75 - NCT07863999RecruitingPhase 3
Immunotherapy before surgery for stage II-III lung cancer
This trial compares two different drug combinations given before surgery for stage II-III non-small cell lung cancer (NSCLC). Both combinations include chemotherapy, and one also includes a newer type of immunotherapy. The goal is to see which approach shrinks tumors more effectively before surgery.
Shanghai, ChinaAges 18 years+ - NCT02308917Recruiting
Canadian children's inflammatory bowel disease study
This study follows children with inflammatory bowel disease (IBD) to learn more about the disease and improve care. It may help doctors understand how to treat Crohn's disease, ulcerative colitis, or IBD that doesn't fit either diagnosis.
Calgary, AlbertaAges 2–17 - NCT07856498Recruiting
Understanding pain and movement in postmenopausal women with low back pain
This study looks at how thoughts and fears about pain affect physical activity in women after menopause who have chronic low back pain. The goal is to learn more about these connections to help improve future treatments.
Istanbul, IstanbulAges 45–65 - NCT07865065Recruiting
Perineal care training for first-time mothers
This study tests a special training program for first-time mothers to improve recovery after giving birth. It aims to improve quality of life after delivery by teaching better care for the area between the vagina and anus (perineum).
Hradec KrálovéAges 18 years+ - NCT06251388RecruitingPhase 2
Chemoradiation plus Cadonilimab for advanced cervical cancer
This trial tests whether adding an immunotherapy drug called Cadonilimab (AK104) to standard chemoradiation can help people with locally advanced cervical cancer that has not spread to distant organs. The goal is to improve treatment outcomes for those who cannot have surgery.
Chengdu, SichuanAges 18–75 - NCT06250595Recruiting
European rare blood disorder registry
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
Barcelona, CataloniaAges Up to 100 years - NCT06254521RecruitingPhase 2
Tislelizumab plus chemo before surgery for MSS rectal cancer
This trial tests a combination of an immunotherapy drug (tislelizumab) plus chemotherapy before surgery for people with a specific type of rectal cancer that has not spread to other organs. The goal is to see if this approach can shrink the tumor more effectively than standard treatment.
Nanning, GuangxiAges 18 years+ - NCT06254560RecruitingPhase 2
Rituximab for severe aplastic anemia with platelet transfusion problems
This study tests if the drug rituximab can help people with severe aplastic anemia whose bodies have stopped responding to platelet transfusions. It aims to see if rituximab can improve the body's ability to accept platelets again.
Tianjin, Tianjin MunicipalityAges 18–70
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,148 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.